Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease. 

 At Replimune, we live by our values: 

United: We Collaborate for a Common Goal. 

Audacious: We Are Bold and Innovative. 

Dedicated: We Give Our Full Commitment. 

Candid: We Are Honest With Each Other. 

People are at the center of everything we do, and when it comes to our employees, we make it personal.  With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients.  

 Join us, as we reshape the future. 

Replimune is currently looking for an individual to join our Commercial Operations team as a Director Data, Analytics and Reporting. This role will report into the Executive Director Commercial Operations. The successful candidate will be responsible for leading commercial data management, analytics and reporting for Replimune as we build out the Commercial organization. The individual in this role is expected to thrive in a fast-paced work environment, prioritize and manage their time effectively, and take initiative to identify and analyze critical unmet needs in the commercial group.

 This position is based in our Woburn office and welcomes hybrid work! Local candidates are expected to be on-site 2 days per week. 

• Work with key stakeholders across the commercial organization in a consultative fashion (Sales, Marketing, Market Research, Market Access colleagues) to execute data strategy, standard analytics (dashboards, KPI reporting), and ad-hoc advanced analysis.
• Work closely with Market Research team to develop strong understanding of the Melanoma market.
• Work closely with the data warehouse IT team in sourcing, procurement, and integration of data from various vendors and sources
• Deliver key strategic and tactical contributions to Commercial data strategy, governance, and stewardship.
• Lead the development and tracking of launch KPIs and goals in collaboration with Sales and Marketing
• Deliver key analytics efforts such as segmentation, marketing mix, digital analytics, triggers and other ROI processes to support evaluation of pre-launch and promotional activities.
• Build out, manage, and update business intelligence dashboards and field reporting tools.
• Conduct data analysis in areas such as use and adoption of brands within indication, persistency, etc.
• Provide thought leadership to direct vendor analyses in advanced analytics.
• Develop regular presentations for key stakeholders including Marketing Team and Senior Leadership.

Education:   

• Bachelor’s Degree required, MBA or similar preferred

  Required Experience: 

•  7+ years relevant analytics or consulting experience in the pharmaceutical industry and at least 4 years managing data, analytics and reporting
• Consulting experience preferred
• Oncology experience strongly preferred
• Functional knowledge, coupled with business acumen, personal credibility, and outstanding leadership skills
• Excellent verbal and written communication skills with the ability to effectively interact with all levels within the company, and demonstrated ability to manage by influence and problem-solve in a highly matrixed organization
• Extensive experience with data analytics including analysis of longitudinal patient claims data, EMR and lab data, hands-on experience with tableau, Power BI, or similar
• Ability to write code to query data and conduct analysis (SQL, SAS, R, and/ or similar)
• Experience in building dashboards and reports for senior leadership and field teams

About Replimune  
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com. 

We are an Equal Opportunity Employer. 

#LI-Hybrid